Persistence Market Research

Cardiac Rhythm Management Market - Size, Share, Trends Analysis and Global Forecast to 2020

Persistence Market Research is released upcoming report on title "Cardiac Rhythm Management Market: Global Industry Analysis and Forecast to 2020".

 

New York, NY -- (SBWIRE) -- 02/12/2015 -- Cardiac rhythm management refers to a process of monitoring functioning of the heart throughdevices. Cardiac rhythm management devicesareused to provide therapeutic solutions to patients suffering from cardiac disorderssuch as cardiac arrhythmias, heart failure, and cardiac arrests. Cardiac disorders lead to irregular heartbeat. Technologicaladvancementsand rise in the number of deaths due to increasing incidences of heart diseases and increasing aging population are some of the major factors driving the cardiac rhythm management market. Heart disease is one of the primary causes of death in the U. S. Excess of alcohol consumption; smoking, high cholesterol levels, and obesity are some of the major causes of heart diseases. Cardiac rhythm management is conducted through two majordevices: implantable cardiac rhythm devices and pacemakers. Implantable cardiac rhythm devices treat patients with improper heartbeat. Based on device, the cardiac rhythm management market can be segmented into defibrillators, pacemakers, cardiac resynchronization therapy devices, implantable defibrillators, and external defibrillators. Pacemakersare used to treat patients with slow heartbeat. Based on end user, the cardiac rhythm management market can be segmented intohospitals, home/ambulatory, and others.

Buy Full Report: http://www.persistencemarketresearch.com/market-research/cardiac-rhythm-management-market.asp

North Americahas the largest market for cardiac rhythm management due to improved healthcare infrastructure, government initiatives, rise in incidences of cardiac disorders, growing number of deaths due to cardiovascular diseases,and increasing healthcare expenditure in the region. The North America market for cardiac rhythm management is followed by Europe. Asia is expected to witness high growth rate in thecardiac rhythm management market in the next few years due toincreasing incidences of cardiovascular diseases, growing disposable income, rise in awareness regarding heart disorders and relevant treatments, and improving healthcare infrastructure in the region.

Increasing prevalence of cardiovascular diseases, technological advancements, rise in life expectancy, increasing awareness regarding cardiac disorders, andgovernment initiatives are some of the major factors that are expected to drive the market for cardiac rhythm management . In addition,factors such as rise in disposable income, increasing aging population, and high cost associated with heart disease treatment areexpected to drive the market for cardiac rhythm management. However, economic downturn, reimbursement issues , importance of biologics and stem cells ,and inappropriate use of the devices are some of the factors restraining growth of the global cardiac rhythm management market.

Growing population and economies in the developing countries such as India and China areexpected to drive growth of the cardiac rhythm management market in Asia. In addition,factors such as innovations along with technological advancements such asminiaturization, introduction of MRI pacemakers,biocompatible materials and durable batteries, and continuous rise in aging population and increasing cardiovascular diseases such as arrhythmias, stroke, and high blood pressure areexpected to create new opportunities for the global cardiac rhythm management market. Increasing number of mergers and acquisitions, rise in the number of collaborations and partnerships, and new product launches are some of the latest trends in the global cardiac rhythm management market. Some of the major companies operating in the global cardiac rhythm management market are Medtronic, Abbott Laboratories, Boston Scientific, St. Jude Medical, Altera, and Sorin. Other companies with significant presence in the global cardiac rhythm management market includeBiotronik, Mentice AB, Philips Healthcare, GE Healthcare, 3M pharmaceuticals,Guidant, and ELA Medical.

Request Full Toc: http://www.persistencemarketresearch.com/toc/3868

Key points covered in the report:

1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)

2) The report covers geographic segmentation

North America
Europe
Asia
RoW

3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020

4) The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market.

Visit our blog at: http://pmrblog.com/

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.